Tag Archives: Russia

U.S. extends arms control treaty with Russia for 5 years, Blinken says

WASHINGTON (Reuters) – The United States on Wednesday extended the New START arms control treaty with Russia for five years, ensuring verifiable limits on Russia, U.S. Secretary of State Antony Blinken said.

President Joe Biden’s administration said it would seek the extension shortly after Biden took office last month. The treaty, which is due to expire on Feb. 5, limits the United States and Russia to deploying no more than 1,550 strategic nuclear warheads each.

It is the last major pact of its kind between Russia and the United States.

“Extending the New START Treaty ensures we have verifiable limits on Russian ICBMs, SLBMs, and heavy bombers until February 5, 2026,” Blinken said in a statement.

In addition to restricting the number of deployed strategic nuclear weapons to its lowest level in decades, New START also limits the land- and submarine-based missiles and bombers that deliver them.

Russian President Vladimir Putin on Jan. 29 signed a law extending New START by five years. Russia said the extension will take effect when the two sides exchange diplomatic notes.

The Russian foreign ministry welcomed the U.S. move on Wednesday, saying the extension “guarantees the necessary level of predictability and transparency in this area while strictly observing a balance of interests.”

The treaty’s lapse would end all restraints on deployments of U.S. and Russian strategic nuclear warheads and the delivery systems that carry them, potentially fueling a new arms race, policy experts have said.

“Especially during times of tension, verifiable limits on Russia’s intercontinental-range nuclear weapons are vitally important,” Blinken said.

“Extending the New START Treaty makes the United States, U.S. allies and partners, and the world safer. An unconstrained nuclear competition would endanger us all.”

(Reporting by Doina Chiacu and Susan Heavey; Editing by Chizu Nomiyama, Paul Simao, Alexandra Hudson)

Oil jumps 2%, hits highest in year as producers limit supply

By Jessica Resnick-Ault

NEW YORK (Reuters) – Oil prices rose more than 2% on Tuesday, reaching their highest in 12 months after major producers showed they were reining in output roughly in line with their commitments.

The U.S. and global benchmarks rallied as optimism about more U.S. economic stimulus added to market bullishness from supply cuts.

Brent crude was up $1.22, or 2.2%, at $57.57 a barrel by 12:03 EST (1703 GMT) for its third straight day of gains, touching $58.05, the highest levels since January last year.

U.S. oil gained $1.26, or 2.3%, to $54.81, after touching a session high of $55.26, the highest in a year.

The rally began as OPEC production increases were less than expected.

OPEC crude production rose for a seventh month in January but the increase was smaller than expected, a Reuters survey found.

Voluntary cuts of 1 million bpd by OPEC’s de facto leader, Saudi Arabia, are set to be implemented from the beginning of February through March.

Russian output increased in January but is in line with the supply pact, while in Kazakhstan oil volumes fell for the month.

The rally picked up steam as the U.S. Congress looked ready to adopt an economic stimulus package, and as cold U.S. weather boosted heating oil demand.

“You got the U.S. economic stimulus package that no one thought we would get,” said Bob Yawger, director of energy futures at Mizuho in New York.

A cold snap and heavy snow in the U.S. northeast drove the margin for heating oil to an 8-month high of $15.88, lending further support to crude.

However, energy giant BP flagged a difficult start to 2021 amid declining product demand, noting that January retail volumes were down about 20% year on year, compared with a decline of 11% in the fourth quarter.

Oil demand is nevertheless expected to recover in 2021, BP said, with global inventories seen returning to their five-year average by the middle of the year.

(Additional reporting by Noah Browning and Aaron Sheldrick; Editing by David Evans, David Goodman and David Gregorio)

Russia’s Sputnik V vaccine 92% effective in fighting COVID-19

By Polina Ivanova

MOSCOW (Reuters) -Scientists gave Russia’s Sputnik V vaccine the green light on Tuesday saying it was almost 92% effective in fighting COVID-19 based on peer-reviewed late-stage trial results published in The Lancet international medical journal.

Experts said the Phase III trial results meant the world had another effective weapon to fight the deadly pandemic and justified to some extent Moscow’s decision to roll out the vaccine before final data had been released.

The results, collated by the Gamaleya Institute in Moscow that developed and tested the vaccine, were in line with efficacy data reported at earlier stages of the trial, which has been running in Moscow since September.

“The development of the Sputnik V vaccine has been criticized for unseemly haste, corner cutting, and an absence of transparency,” said Ian Jones, professor at the University of Reading, and Polly Roy, professor at the London School of Hygiene & Tropical Medicine.

“But the outcome reported here is clear and the scientific principle of vaccination is demonstrated,” the scientists, who were not involved in the study, said in a comment shared by The Lancet. “Another vaccine can now join the fight to reduce the incidence of COVID-19.”

The results were based on data from 19,866 volunteers, of whom a quarter received a placebo, the researchers, led by the Gamaleya Institute’s Denis Logunov, said in The Lancet.

Since the trial began in Moscow, there were 16 recorded cases of symptomatic COVID-19 among people who received the vaccine, and 62 among the placebo group, the scientists said.

This showed that a two-dose regimen of the vaccine – two shots based on two different viral vectors, administered 21 days apart – was 91.6% effective against symptomatic COVID-19.

‘RUSSIA WAS RIGHT’

The Sputnik V vaccine is the fourth worldwide to have Phase III results published in leading peer-reviewed medical journals following the shots developed by Pfizer and BioNTech, Moderna and AstraZeneca.

Pfizer’s shot had the highest efficacy rate at 95%, closely followed by Moderna’s vaccine and Sputnik V while AstraZeneca’s vaccine had an average efficacy of 70%.

Sputnik V has also now been approved for storage in normal fridges, as opposed to freezers, making transportation and distribution easier, Gamaleya scientists said on Tuesday.

Russia approved the vaccine in August, before the large-scale trial had begun, saying it was the first country to do so for a COVID-19 shot. It named it Sputnik V, in homage to the world’s first satellite, launched by the Soviet Union.

Small numbers of frontline health workers began receiving it soon after and a large-scale roll out started in December, though access was limited to those in specific professions, such as teachers, medical workers and journalists.

In January, the vaccine was offered to all Russians.

“Russia was right all along,” Kirill Dmitriev, head of the Russian Direct Investment Fund (RDIF), which is responsible for marketing the vaccine abroad, told reporters on Tuesday.

He said the results supported Russia’s decision to begin administering Sputnik V to frontline workers while the trial was still underway, and suggested skepticism of such moves was politically motivated.

“The Lancet did very unbiased work despite some of the political pressures that may have been out there,” he said.

EFFECTIVE IN ELDERLY

The number of people vaccinated in Russia has remained low so far. Authorities have pointed to some early issues with scaling up production while polls have shown low demand among Russians for the vaccine.

Russia has already shared data from its Phase III trial with regulators in several countries and has begun the process of submitting it to the European Medicines Agency (EMA) for approval in the European Union, Dmitriev said.

The data release comes as Europe scrambles to secure enough shots for its 450 million citizens due to production cuts by AstraZeneca and Pfizer. The U.S. roll-out, meanwhile, has been hampered by the need to store shots in ultra-cold freezers and uneven planning across states.

There were 2,144 volunteers over 60 in the Sputnik V trial and the shot was shown to be 91.8% effective when tested on this older group, with no serious side-effects reported that could be associated with the vaccine, The Lancet summary said.

RDIF’s Dimitriev also said the Gamaleya Institute was testing the vaccine against new variants of COVID-19 and the early signs were positive.

The vaccine was also found to be 100% effective against moderate or severe COVID-19, as there were no such cases among the group of 78 participants who were infected and symptomatic at 21 days after the first shot was administered.

Four deaths of participants occurred, but none was considered associated with vaccination, The Lancet said.

“The efficacy looks good, including in the over 60’s,” said Danny Altmann, a professor of immunology at Imperial College London. “It’s good to have another addition to the global arsenal.”

ONE DOSE VERSION

The authors of the study noted that because COVID-19 cases were only detected when trial participants reported symptoms, further research was needed to understand Sputnik V’s efficacy on asymptomatic cases and transmission.

Sputnik V has been approved by 15 countries, including Argentina, Hungary and the United Arab Emirates and this will rise to 25 by the end of next week, the RDIF’s Dmitriev said.

The sovereign wealth fund also said vaccinations using Sputnik V will begin in a dozen countries including Bolivia, the United Arab Emirates, Venezuela and Iran.

Hungary was the first member of the European Union to break ranks and unilaterally approve the vaccine last month. It is set to receive a first batch of 40,000 doses on Tuesday.

Germany has said it would use Sputnik V if it is approved by Europe’s drug regulator while France has said it could buy any efficient vaccine.

However, large shipments of the shot have only been sent so far to Argentina, which has received enough doses to vaccinate about 500,000 people.

“Now all doubts are cleared up,” Argentine Science Minister Roberto Salvarezza told local radio station La Red, citing “the confirmation in a prestigious scientific publication.”

Production for export will primarily be done by RDIF’s manufacturing partners abroad, the fund has said.

On Tuesday, Dmitriev said production had started in India and South Korea, and would launch in China this month. Trial doses have also been produced by a manufacturer in Brazil.

Russia is conducting a small-scale clinical trial of a one-dose version of the vaccine, which developers expect to have an efficacy rate of 73% to 85%.

(Additional reporting by Kate Kelland in London and Nicolas Misculin in Buenos Aires; Writing by Polina Ivanova; Editing by Mark Potter and David Clarke)

After mass arrests at protests, Moscow jail space in short supply

By Maria Tsvetkova

MOSCOW (Reuters) – Anti-Kremlin protester Filipp Kuznetsov was detained in Moscow on Saturday and found guilty by a court on Monday of taking part in an illegal protest. But it was only late on Wednesday that the authorities were able to find a jail cell for him.

After arresting what one monitoring group said was a record number of protesters at weekend rallies demanding Kremlin critic Alexei Navalny be freed from jail, Moscow police appear to be struggling to find enough space in detention facilities.

Tens of thousands of protesters took to the streets across Russia on Saturday to demand the release of Navalny, who was arrested at a Moscow airport this month after flying home for the first time since being poisoned with a nerve agent.

Kuznetsov, a 28-year-old entrepreneur, was arrested on Saturday near the prison housing Navalny. A court on Monday sentenced Kuznetsov to 10 days in jail for taking part in the protests, deemed illegal because they had not been pre-sanctioned by the authorities.

“I’m sitting in a police bus because there is no space in the jails,” Kuznetsov told Reuters by phone on Wednesday afternoon.

He said he knew Moscow’s jails were full from policemen who had guarded him and 17 other protesters in a police bus overnight outside a jail that had refused to accept them because it was full.

Kuznetsov messaged later on Wednesday to say the police had eventually found a prison for him after driving from jail to jail for more than 16 hours.

The policemen guarding him and the others had allowed volunteers to bring food while they were waiting in the bus and had sometimes escorted them to the nearby jail to use the bathroom, Kuznetsov said.

By the time he got to jail, he said he had not slept for over 30 hours.

“Free people don’t get tired. We support each other,” he said.

The Moscow police department did not respond to a request for comment.

MASS ARRESTS

The OVD-info protest monitoring group, which counts arrests one by one and offers legal support, said police on Saturday detained nearly 4,000 people at protests across Russia, over 1,500 of them in Moscow.

It said it had compared the figures with the number of arrests counted at previous protests, and found both were record figures for President Vladimir Putin’s long rule.

“The number of people arrested after the rallies was really big and there is no space for them in Moscow jails,” said Grigory Durnovo, an OVD-info analyst.

Putin has called the pro-Navalny marches illegal. Kremlin critics cite their constitutional right to protest.

(Reporting by Maria Tsvetkova and Mikhail Antonov, Editing by Andrew Osborn and Timothy Heritage)

Russian lawmakers approve extension of nuclear arms pact with U.S.

MOSCOW (Reuters) – Russia’s parliament on Wednesday approved a five-year extension of the New START nuclear arms control treaty with the United States, which a senior official said had been agreed on Moscow’s terms at the eleventh hour before it expires next week.

Signed in 2010, the New START (Strategic Arms Reduction Treaty) is a cornerstone of global arms control and limits the numbers of strategic nuclear warheads, missiles and bombers that Russia and the United States can deploy.

The White House did not immediately confirm a Kremlin announcement on Tuesday of a deal to extend the treaty but said new President Joe Biden and Russian President Vladimir Putin had discussed the issue by telephone and agreed that their teams work urgently to complete the pact by Feb. 5, the expiry date.

Both Russia’s lower and upper houses of parliament, the State Duma and Federation Council, rushed through votes on Wednesday to approve the extension of the last major pact of its kind between the two nuclear powers.

“The essence of the agreement is to extend it for five years, as it was signed, without any changes,” Deputy Foreign Minister Sergei Ryabkov told the Duma.

The next step is expected to be President Vladimir Putin signing the legislation.

Ryabkov said the treaty would be formally extended once Russia and the United States had exchanged diplomatic notes after completing all their respective domestic procedures.

He said the extension had been agreed “on our terms,” the TASS news agency reported.

Moscow and Washington had failed to agree an extension under former U.S. President Donald Trump, whose administration had wanted to attach conditions to a renewal that Moscow rejected.

Addressing a virtual meeting of the World Economic Forum, Putin cast the extension as “a step in the right direction” – at a time when U.S.-Russian relations are strained in other areas.

Konstantin Kosachev, chairman of the international affairs committee of the Federation Council, described it as a good treaty that ensured Russia’s national security.

“If the treaty had not been extended, ceilings and quantitative limits would have disappeared, which would open the opportunity for an arms race,” he said.

(Reporting by Anton Kolodyazhnyy, Darya Korsunskaya, Elena Fabrichnaya and Alexander Marrow; Editing by Tom Balmforth and Mark Heinrich)

Global COVID-19 cases surpass 100 million as nations tackle vaccine shortages

By Shaina Ahluwalia and Roshan Abraham

(Reuters) – Global coronavirus cases surpassed 100 million on Wednesday, according to a Reuters tally, as countries around the world struggle with new virus variants and vaccine shortfalls.

Almost 1.3% of the world’s population has now been infected with COVID-19, the disease caused by the novel coronavirus, and more than 2.1 million people have died.

One person has been infected every 7.7 seconds, on average, since the start of the year. Around 668,250 cases have been reported each day over the same period, and the global fatality rate stands at 2.15%.

The worst-affected countries – the United States, India, Brazil, Russia and the United Kingdom – make up more than half all reported COVID-19 cases but represent 28% of the global population, according to a Reuters analysis.

It took the world 11 months to record the first 50 million cases of the pandemic, compared to just three months for cases to double to 100 million.

Around 56 countries have begun vaccinating people for the coronavirus, administering at least 64 million doses. Israel leads the world on per capita vaccinations, inoculating 29% of its population with at least one dose.

UNITED STATES

With over 25 million cases, the United States has 25% of all reported COVID cases although it accounts for just 4% of the world’s population. The United States leads the world in the daily average number of new deaths reported, accounting for one in every five deaths reported worldwide each day. With just under 425,00 fatalities, the United States has reported almost twice as many deaths as Brazil, which has the second-highest death toll in the world.

As the worst-affected region in the world, Europe is currently reporting a million new infections about every four days and has reported nearly 30 million since the pandemic began. Britain on Tuesday reached 100,000 deaths.

The Eastern European region, including countries like Russia, Poland and Ukraine, contribute to nearly 10% of all global COVID-19 cases.

Despite securing deals for vaccine supplies early on, many European countries are facing delays in shipments from both Pfizer Inc and AstraZeneca Plc.

ASIA AND AFRICA

In India, the nation with the second-highest number of cases, infections are decreasing, with almost 13,700 new infections reported on average each day – around 15% of its peak. Prime Minister Narendra Modi said on Friday India was completely self-reliant on coronavirus vaccine supplies as the world’s second-most populous country inoculated more than 1 million people within a week of starting its campaign.

China, which recently marked the first anniversary of the world’s first coronavirus lockdown in the central city of Wuhan, is facing its worst wave of local cases since March last year.

As richer nations race ahead with mass vaccination campaigns, Africa is still scrambling to secure supplies as it grapples with concerns about more-infectious variants of the virus first identified in South Africa and Britain.

According to the Reuters tally, African countries have nearly 3.5 million cases and over 85,000 deaths.

The South African variant, also known as 501Y.V2, is 50% more infectious and has been detected in at least 20 countries.

U.S. President Joe Biden will impose a ban on most non-U.S. citizens entering the country who have recently been in South Africa starting Saturday in a bid to contain the spread of a new variant of COVID-19.

Australia and New Zealand have fared better than most other developed economies during the pandemic through swift border closures, lockdowns, strict hotel quarantine for travelers and widespread testing and social distancing.

“We have the virus under control here in Australia, but we want to roll out the vaccine,” Australian Treasurer Josh Frydenberg told a news conference on Sunday.

(Reporting by Shaina Ahluwalia and Roshan Abraham in Bengaluru; Editing by Lisa Shumaker and Jane Wardell)

Biden seeks five-year extension of New START arms treaty with Russia

WASHINGTON (Reuters) – U.S. President Joe Biden will seek a five-year extension to the New START arms control treaty with Russia, the White House said on Thursday, in one of the first major foreign policy decisions of the new administration ahead of the treaty’s expiration in early February.

“The President has long been clear that the New START treaty is in the national security interests of the United States. And this extension makes even more sense when the relationship with Russia is adversarial as it is at this time,” White House press secretary Jen Psaki said in a briefing.

She also said Biden had “tasked” the U.S. intelligence community for its full assessment of the Solar Winds cyber breach, Russian interference in the 2020 election, Russia’s use of chemical weapons against opposition leader Alexei Navalny and alleged bounties on U.S. soldiers in Afghanistan.

“Even as we work with Russia to advance U.S. interests, so too we work to hold Russia to account for its reckless and adversarial actions,” Psaki said.

The arms control treaty, which is due to expire on Feb. 5, limits the United States and Russia to deploying no more than 1,550 strategic nuclear warheads each.

In addition to restricting the number of deployed strategic nuclear weapons to its lowest level in decades, New START also limits the land- and submarine-based missiles and bombers that deliver them.

The treaty’s lapse would end all restraints on deployments of U.S. and Russian strategic nuclear warheads and the delivery systems that carry them, potentially fueling a new arms race, policy experts have said.

Earlier, a source familiar with the decision told Reuters that U.S. lawmakers have been briefed on Biden’s decision on the New START treaty.

The Kremlin said on Wednesday it remained committed to extending New START and would welcome efforts promised by the Biden administration to reach agreement.

(Reporting by Arshad Mohammed and Jeff Mason; Writing by Humeyra Pamuk and Susan Heavey; Editing by Doina Chiacu and Bill Berkrot)

U.S. counter-intelligence chief worried about China, Russia threats to vaccine supply chain

By Jonathan Landay

WASHINGTON (Reuters) – The U.S. counter-intelligence chief said on Tuesday he was worried about threats from China and Russia to disrupt the coronavirus vaccine supply chain in the United States.

William Evanina, director of the U.S. National Counterintelligence and Security Center, told an online Washington Post event that U.S. adversaries were trying to interfere with Operation Warp Speed, the U.S. government operation distributing the vaccines.

“Our adversaries are trying to disrupt that supply chain,” he said. Asked which adversaries he was particularly concerned about, he replied, “I would say China and Russia right now.”

The Chinese and Russian embassies did not immediately respond to requests for comment on Evanina’s assertion. Russia and China have denied U.S. accusations that hackers linked to both governments tried to steal data from vaccine manufacturers.

U.S. states are scrambling to accelerate inoculations as infections and deaths surge – COVID-19 has claimed on average about 3,200 lives nationwide every day over the past week.

Since the pandemic began more than 10 months ago nearly 375,000 people in the country have died, according to a Reuters count.

Evanina said that his agency was working with the U.S. Army and the Department of Health and Human Services to ensure the safe “transportation” of the vaccines “from the manufacturing site to the end-user inoculation.”

Vaccines available are made by Pfizer and BioNTech and Moderna. Nearly 9 million Americans have received the first of two doses, according to the U.S. Centers for Disease Control and Prevention, less than one-third of the 25 million doses distributed by the federal government.

Public health experts have said no U.S. state has so far come close to using up its federal vaccine allotments, a much slower-than-expected roll-out blamed in part on rigid rules sharply limiting who can be inoculated.

(Reporting by Jonathan Landay; Writing by Doina Chiacu; Editing by Rosalba O’Brien and Grant McCool)

U.S. senators ask IRS if hacking campaign compromised taxpayer data

By Susan Heavey

WASHINGTON (Reuters) – Two top U.S. Senators on Thursday said they were seeking answers on whether the recent hacking attack against the federal government compromised U.S. taxpayers’ data, which could make millions of Americans more vulnerable to identity theft and other crimes.

As officials continued to assess damage from the cyberattack, U.S. Senate Finance Committee Chairman Chuck Grassley and ranking Democrat Ron Wyden asked the Internal Revenue Service whether the tax agency was affected and, if so, what it was doing to mitigate the fallout and protect against further intrusions.

The sweeping campaign, done by hackers believed to be working for Russia, leveraged technology from SolarWinds Corp used by multiple U.S. government agencies and other businesses, Reuters has reported.

The U.S. government has not publicly identified who might be behind the massive intrusion, and several U.S. lawmakers on Thursday said it appeared that U.S. officials were still analyzing the impact of the attack.

“I think the government is still assessing how bad the damage is,” Senator Mark Warner, the ranking Democrat on the Senate intelligence panel, told MSNBC in an interview.

Grassley and Wyden, in their letter, sought an immediate briefing from IRS Commissioner Chuck Rettig on the impact to U.S. taxpayers, whose sensitive financial records are filed each year with the agency.

The IRS has used SolarWinds technology as recently as 2017, they said.

“Given the extreme sensitivity of personal taxpayer information entrusted to the IRS, and the harm both to Americans’ privacy and our national security that could result from the theft and exploitation of this data by our adversaries, it is imperative that we understand the extent to which the IRS may have been compromised,” the senators wrote.

(Reporting by Susan Heavey; Editing by David Gregorio)

Trump pardons former adviser Flynn

WASHINGTON (Reuters) – U.S. President Donald Trump on Wednesday pardoned his former national security adviser Michael Flynn who had pleaded guilty to lying to the FBI during the investigation into Russian meddling in the 2016 presidential election.

“It is my Great Honor to announce that General Michael T. Flynn has been granted a Full Pardon. Congratulations to @GenFlynn and his wonderful family, I know you will now have a truly fantastic Thanksgiving!” Trump wrote on Twitter.

A retired Army general, Flynn pleaded guilty in 2017 to lying to the FBI about interactions he had with Russia’s ambassador to the United States in the weeks leading up to Trump’s inauguration in January 2017.

He has since sought to withdraw the plea, arguing that prosecutors violated his rights and duped him into a plea agreement. His sentencing has been deferred several times.

Flynn was one of several former Trump aides to plead guilty or be convicted at trial in former Special Counsel Robert Mueller’s investigation into Moscow’s interference in the 2016 U.S. election to boost Trump’s candidacy. Russia denied meddling.

Trump in March said he was strongly considering a full pardon for Flynn. He said the FBI and Justice Department had “destroyed” Flynn’s life and that of his family.

The Justice Department has repeatedly denied allegations of prosecutorial misconduct, and U.S. District Court Judge Emmet Sullivan rejected all of Flynn’s claims in December 2019.

Federal prosecutors had asked the judge in January to sentence Flynn to up to six months in prison, arguing in a court filing that “the defendant has not learned his lesson. He has behaved as though the law does not apply to him, and as if there are no consequences for his actions.”

Flynn joined the Trump 2016 election campaign and at the Republican National Convention that year he led supporters in chants of “Lock her up,” in reference to Democratic candidate Hillary Clinton.

(Reporting by Eric Beech; Writing by Alistair Bell; Editing by Tim Ahmann and Howard Goller)